Alejandro Martí

654 total citations
22 papers, 406 citations indexed

About

Alejandro Martí is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Alejandro Martí has authored 22 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in Alejandro Martí's work include Photodynamic Therapy Research Studies (6 papers), Porphyrin and Phthalocyanine Chemistry (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Alejandro Martí is often cited by papers focused on Photodynamic Therapy Research Studies (6 papers), Porphyrin and Phthalocyanine Chemistry (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Alejandro Martí collaborates with scholars based in Switzerland, Colombia and United States. Alejandro Martí's co-authors include Norbert Lange, Patrice Jichlinski, Pavel Kučera, L Guillou, Hubert van den Bergh, Georges Wagnières, Martin Forrer, Matthieu Zellweger, J.–P. Ballini and Hans‐Jürg Leisinger and has published in prestigious journals such as The Journal of Urology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Alejandro Martí

19 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Martí Switzerland 4 280 186 173 87 80 22 406
W. Lumper Germany 8 399 1.4× 321 1.7× 244 1.4× 70 0.8× 53 0.7× 15 524
U.O. Nseyo United States 8 267 1.0× 192 1.0× 124 0.7× 40 0.5× 29 0.4× 15 381
Jérôme C. Mizeret Switzerland 10 365 1.3× 318 1.7× 143 0.8× 51 0.6× 22 0.3× 23 485
Scott L. Lundahl United States 9 291 1.0× 255 1.4× 98 0.6× 55 0.6× 14 0.2× 11 358
Hideo Fukuhara Japan 13 190 0.7× 147 0.8× 209 1.2× 27 0.3× 33 0.4× 30 510
Nicholas J. Razum United States 9 362 1.3× 241 1.3× 32 0.2× 111 1.3× 42 0.5× 13 442
C. S. Loh United Kingdom 9 564 2.0× 439 2.4× 114 0.7× 182 2.1× 47 0.6× 11 602
Jolanda van den Boogert Netherlands 11 311 1.1× 171 0.9× 186 1.1× 42 0.5× 10 0.1× 13 423
Michael Mehlmann Germany 5 239 0.9× 159 0.9× 64 0.4× 22 0.3× 16 0.2× 6 339
Yoshitaka Nagatsuka Japan 5 212 0.8× 187 1.0× 52 0.3× 83 1.0× 40 0.5× 13 327

Countries citing papers authored by Alejandro Martí

Since Specialization
Citations

This map shows the geographic impact of Alejandro Martí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Martí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Martí more than expected).

Fields of papers citing papers by Alejandro Martí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Martí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Martí. The network helps show where Alejandro Martí may publish in the future.

Co-authorship network of co-authors of Alejandro Martí

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Martí. A scholar is included among the top collaborators of Alejandro Martí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Martí. Alejandro Martí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Moreno, Víctor, Todd M. Bauer, Jon Infante, et al.. (2016). A phase I, open-label, study of GSK2879552, a lysine-specific demethylase 1 (LSD1) inhibitor, in patients with relapsed/refractory small cell lung carcinoma (SCLC). Annals of Oncology. 27. vi121–vi121. 1 indexed citations
4.
Brocard, Fabien, Marianne Leheurteur, Jérôme Dauba, et al.. (2016). Phase II trial evaluating the combination of eribulin (E)+ bevacizumab (BEV) as first line chemotherapy in patients with metastatic Her2-negative breast cancer (MBC): a GINECO group study. Annals of Oncology. 27. vi72–vi72. 1 indexed citations
5.
Martí, Alejandro, et al.. (2015). Metástasis pancreática, sitio inusual de diseminación por cáncer de tiroides. Documentada por PET CT/FDG y estudio histopatológico. Revista Colombiana de Cancerología. 19(3). 184–190. 1 indexed citations
6.
7.
Martí, Alejandro, et al.. (2011). Utilidad del citrato de galio 67 en el diagnóstico de fiebre de origen desconocido. Revista Colombiana de Cancerología. 15(1). 46–49. 1 indexed citations
8.
Martí, Alejandro. (2010). Simón Radowitzky : la biografía del anarquista : del atentado a Falcón a la Guerra Civil Española. Medical Entomology and Zoology. 1 indexed citations
9.
Mayadağlı, Alpaslan, et al.. (2008). Outcome of metastatic non-small cell lung carcinoma patients receiving docetaxelcisplatin combination chemotherapy: single institution experience.. PubMed. 12(4). 471–6. 2 indexed citations
10.
Basset, Sabine Collaud, Patrice Jichlinski, Alejandro Martí, et al.. (2006). An Open Pharmacokinetic Study of??Hexylaminolevulinate-Induced Photodiagnosis after Intravesical Administration. Drugs in R&D. 7(3). 173–186. 6 indexed citations
11.
Marti, Guy P., Martin A. Makary, Mark W. J. Ferguson, et al.. (2004). Transfection with keratinocyte growth factor 1 cDNA with electroporation improves wound healing in an aged mouse model. Journal of Surgical Research. 121(2). 320–321. 1 indexed citations
12.
Martí, Alejandro, Patrice Jichlinski, Norbert Lange, et al.. (2003). Comparison of Aminolevulinic Acid and Hexylester Aminolevulinate Induced Protoporphyrin IX Distribution in Human Bladder Cancer. The Journal of Urology. 170(2). 428–432. 103 indexed citations
13.
Martí, Alejandro, Patrice Jichlinski, & Hans‐Jürg Leisinger. (2002). Lithiases urétérales, quel traitement ?. Annales d Urologie. 36(2). 107–114.
14.
Jichlinski, Patrice, Alejandro Martí, & Hans‐Jürg Leisinger. (2002). La cystoscopie en fluorescence dans le cancer de la vessie, quel avenir ?. Annales d Urologie. 36(4). 264–268. 2 indexed citations
15.
Jichlinski, Patrice, Alejandro Martí, L Guillou, Norbert Lange, & Georges Wagnières. (2001). First report on hexyl-ester aminolevulinic acid (h-ALA) induced fluorescence cystoscopy in superficial bladder cancer. European Urology. 39. 37. 2 indexed citations
16.
Bergh, Hubert van den, Norbert Lange, Alejandro Martí, Pavel Kučera, & Patrice Jichlinski. (1999). ALA Hexyl Ester: A second generation precursor for protoporphyrin IX in photodynamic therapy and photodetection of early bladder cancer.. IRIS. 3 indexed citations
17.
Lange, Norbert, Patrice Jichlinski, Matthieu Zellweger, et al.. (1999). Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. British Journal of Cancer. 80(1-2). 185–193. 193 indexed citations
18.
Martí, Alejandro, Norbert Lange, Hubert van den Bergh, et al.. (1999). OPTIMISATION OF THE FORMATION AND DISTRIBUTION OF PROTOPORPHYRIN IX IN THE UROTHELIUM: AN IN VITRO APPROACH. The Journal of Urology. 162(2). 546–552. 82 indexed citations
19.
Martí, Alejandro, et al.. (1996). Lung-angiodysplasia and von Willebrand's disease in a family with Rendu-Osler disease. A case report.. PubMed. 87(12). 589–91. 1 indexed citations
20.
Nakagawa, Hiroshi, John O. Lusins, Insun Song, & Alejandro Martí. (1979). SAGITTAL AND CORONAL RECONSTRUCTION IN SPINAL CT. Journal of Computer Assisted Tomography. 3(4). 567–567. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026